Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff.
Carrick DM, Johnson B, Kleinman SH, Vorhaben R, Chance SC, Lee JH, Roback JD, Pandey S, Sun Y, Busch MP, Norris PJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Carrick DM, et al. Among authors: norris pj. Transfusion. 2011 May;51(5):1105-16. doi: 10.1111/j.1537-2995.2010.02938.x. Epub 2010 Nov 18. Transfusion. 2011. PMID: 21087285 Free PMC article.
Risk factors and outcomes in transfusion-associated circulatory overload.
Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson G, Matthay M, Bacchetti P, Toy P; TRALI Study Group. Murphy EL, et al. Am J Med. 2013 Apr;126(4):357.e29-38. doi: 10.1016/j.amjmed.2012.08.019. Epub 2013 Jan 26. Am J Med. 2013. PMID: 23357450 Free PMC article.
The impact of recipient factors on the lower-than-expected hemoglobin increment in transfused outpatients with hematologic diseases.
Karafin MS, Bruhn R, Roubinian NH, Chowdhury D, Qu L, Snyder EL, Murphy EL, Brambilla D, Cable RG, Hilton JF, St Lezin E; NHLBI Recipient Epidemiology and Donor Evaluation (REDS)-III Study. Karafin MS, et al. Transfusion. 2019 Aug;59(8):2544-2550. doi: 10.1111/trf.15439. Epub 2019 Jul 4. Transfusion. 2019. PMID: 31270827 Clinical Trial.
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray.
de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, Adenaiye O, Tai S, Hong F, Norris PJ, Stone M, Simmons G, Bagri A, Schreiber M, Buser A, Holbro A, Battegay M, Hosimer P, Noesen C, Milton DK; Prometheus Study Group; Davies DH, Contestable P, Corash LM, Busch MP, Felgner PL, Khan S. de Assis RR, et al. Among authors: norris pj. bioRxiv [Preprint]. 2020 May 8:2020.04.15.043364. doi: 10.1101/2020.04.15.043364. bioRxiv. 2020. Update in: Nat Commun. 2021 Jan 4;12(1):6. doi: 10.1038/s41467-020-20095-2 PMID: 32511302 Free PMC article. Updated. Preprint.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J Jr, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. Peluso MJ, et al. Among authors: norris pj. medRxiv [Preprint]. 2021 Mar 5:2021.03.03.21251639. doi: 10.1101/2021.03.03.21251639. medRxiv. 2021. Update in: Sci Adv. 2021 Jul 30;7(31):eabh3409. doi: 10.1126/sciadv.abh3409 PMID: 33688675 Free PMC article. Updated. Preprint.
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
Stone M, Di Germanio C, Wright DJ, Sulaeman H, Dave H, Fink RV, Notari EP, Green V, Strauss D, Kessler D, Destree M, Saa P, Williamson PC, Simmons G, Stramer SL, Opsomer J, Jones JM, Kleinman S, Busch MP; NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Stone M, et al. Clin Infect Dis. 2022 Mar 9;74(5):871-881. doi: 10.1093/cid/ciab537. Clin Infect Dis. 2022. PMID: 34111244 Free PMC article.
The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.
Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, Busch MP, Chapman K, Dinardo C, Hendrickson J, Hod EA, Kelly S, Luban N, Mast A, Norris P, Custer B, Sabino E, Sachais B, Spencer BR, Stone M, Kleinman S; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P). Josephson CD, et al. Transfusion. 2022 May;62(5):982-999. doi: 10.1111/trf.16869. Epub 2022 Apr 19. Transfusion. 2022. PMID: 35441384 Free PMC article.
231 results